You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Investigational Drug Information for Ridinilazole


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Ridinilazole?

Ridinilazole is an investigational drug.

There have been 4 clinical trials for Ridinilazole. The most recent clinical trial was a Phase 2 trial, which was initiated on May 19th 2021.

The most common disease conditions in clinical trials are Communicable Diseases, Clostridium Infections, and Infections. The leading clinical trial sponsors are Summit Therapeutics, Department of Health and Human Services, and [disabled in preview].

There is one US patent protecting this investigational drug and fifty-five international patents.

Recent Clinical Trials for Ridinilazole
TitleSponsorPhase
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent SubjectsDepartment of Health and Human ServicesPhase 3
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent SubjectsSummit TherapeuticsPhase 3
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile InfectionSummit TherapeuticsPhase 3

See all Ridinilazole clinical trials

Clinical Trial Summary for Ridinilazole

Top disease conditions for Ridinilazole
Top clinical trial sponsors for Ridinilazole

See all Ridinilazole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.